ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 24 No. 8 | August 31, 2001

Download PDF Visit The Full Archive

Related Articles

NCI awards $42 million for prevention trials consortium.

December 5, 2003

DCPC Advisers Ok Four New Grant Programs To Foster Prevention

May 22, 1992

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

NCI Programs: 15 New Grants Awarded In Survivor Research

October 9, 1998

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

May 25, 2001